Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Patients and members of the public are vital to our research. Without patients choosing to taking part in our clinical trials our research would not be possible. We also have patients advising us on ...

Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...

Work with the Institute of Cancer Research and help people with cancer. Enquire about trusts and foundations today.

PENELOPE B is a phase III international, multicentre, randomised, placebo-controlled, double-blind trial comparing the efficacy and safety of adding palbociclib to standard hormone therapy vs standard ...

The Institute of Cancer Research, London, welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend the targeted drug talazoparib (trade name Talzenna), in ...